This content is from: Trademarks

Lack of trade mark evidence loses domain dispute

A company has lost a UDRP dispute after it failed to produce any evidence of its claimed trade mark licence for pharmaceuticals company Amgen’s mark Kineret

To access our in-house intelligence please request a trial here.

Read this article – and more – for a 30 day period.

REQUEST ACCESS

Are you already an Managing IP subscriber? Login here

Related

Instant access to all of our content. Membership Options | 30 Day Trial